On-site
2026-04-21 - 2026-04-24
ExCeL London, London, United Kingdom

Charing Cross Symposium 2026

At Charing Cross 2026, we are excited to present our brand new ARTIS angiography portfolio powered by AI.

Conference Date: 21 - 23 April, 2026
Location: 
London, UK
Venue:
ExCeL London
Booth: 
206

Add to calendar

Date: April 23rd, 2026
Time: 3.15 - 3.30 m
Location: Theatre 3

Speaker: Prof. Markus Steinbauer
Director of Vascular Surgery, Barmherzige Brueder Hospital, Germany

Add to calendar

ARTIS pheno.vision1 is the advanced robotic imaging system designed to support a highly diverse procedure mix – empowering multiple interventional and surgical disciplines, both today and into the future. ARTIS pheno.vision is powered by OPTIQ AI2, our next-generation imaging chain combining CNR-driven exposure regulation with AI based image noise reduction. Turn your vision into reality - with ARTIS pheno.vision.

  • Ready for current and future demands
  • AI-powered imaging chain
  • Optimize clinical operations
  • Supports you to maintain high infection control standards
Learn more

During minimally invasive procedures, it is critical to have a clear view of anatomies and devices. Yet complex imaging tasks or challenging patient conditions often impact image quality. OPTIQ AI delivers constant image quality3 defined by CNR in support of the ALARA4 principle, independent of patient or C-arm angulation. On top, an AI-powered algorithm reduces image noise in real time across different 2D imaging modes.

Make AI-powered imaging and clear insights your standard during interventions – with OPTIQ AI.

Learn more

Our fixed C-arms with procedural intelligence have been designed to simplify endovascular treatment. They allow you to standardize vascular workflows for routine procedures and guide you through complex cases for excellent patient outcomes. 

Increasing complexity of EVAR repair
Patient demand for complex EVAR procedures is rapidly increasing. Endovascular stent grafts are already the treatment of choice for up to 80% of aortic aneurysm cases in the U.S. today5. We offer a portfolio of Hybrid OR solutions that help standardize all of your workflows, enabling you to perform complex treatment on a routine basis. 

Learn more

You intend to build a new or enhance your existing Hybrid OR? Thanks to 20 years of experience gained from more than 1,450 Hybrid OR installations in 60 countries and supported by many vital industry and clinical partnerships we are prepared to be your trusted partner. You can benefit from our solutions tailored to your needs – from ideation to implementation and routine operations. Leverage our skills in technical, clinical, and economical Hybrid OR planning. Choose from a comprehensive portfolio of state-of-the-art Hybrid OR technologies as well as dedicated education and service solutions. We are looking forward to creating your individual Hybrid OR solution together with you!

Learn more

CIARTIC Move is a new class of robotic C-arm that has the potential to address operational challenges related to intraoperative imaging and overloaded surgical teams.6

With its self-driving and automation capabilities, CIARTIC Move unburdens OR teams by standardizing intraoperative imaging workflows. The robotic technologies effectively reduce the time6, effort, and workforce capacity needed for system positioning during procedures — and simplify moving the device between operating rooms.

  • Move automatically: Accelerate6 and standardize 2D and 3D imaging in the OR
  • Move independently: Avoid idle times and delays in the OR.
  • Move effortlessly: Reduce the physical burden of working in the OR.
Learn more

Are you interested?

Want to know more about Charing Cross 2026?

Official congress website

Want to know more about a product or talk to a sales representative?

Get in touch

Do you find this page interesting? Share the information with peers.

1
2
3
4
5
6
You are entering a global domain of Siemens Healthineers.

If you choose to continue, please note that information in this domain is meant to be generic and country-independent. The devices displayed or mentioned may not be commercially available in all countries and their future availability cannot be guaranteed.

Continue